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Background: In this study we assessed the mediation role of the gestational age on the effect of the infant’s
congenital heart defects (CHD) on birth-weight.
Methods: We used secondary data from the Baltimore-Washington Infant Study (1981–1989). Mediation analysis
was employed to investigate whether gestational age acted as a mediator of the association between CHD and
reduced birth-weight. We estimated the mediated effect, the mediation proportion, and their corresponding 95%
confidence intervals (CI) using several methods.
Results: There were 3362 CHD cases and 3564 controls in the dataset with mean birth-weight of 3071 (SD = 729)
and 3353 (SD = 603) grams, respectively; the mean gestational age was 38.9 (SD = 2.7) and 39.6 (SD = 2.2) weeks,
respectively. After adjusting for covariates, the estimated mediated effect by gestational age was 113.5 grams
(95% CI, 92.4–134.2) and the mediation proportion was 40.7% (95% CI, 34.7%–46.6%), using the bootstrap approach.
Conclusions: Gestational age may account for about 41% of the overall effect of heart defects on reduced infant
birth-weight. Improved prenatal care and other public health efforts that promote full term delivery, particularly
targeting high-risk families and mothers known to be carrying a fetus with CHD, may therefore be expected to
improve the birth-weight of these infants and their long term health.
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Congenital heart defects (CHD), also known as congenital
cardiovascular malformations, are the most common type
of structural birth defects and have substantial effects on
pediatric mortality and morbidity [1,2]. The prevalence of
CHD in the live-born population of the United States is
estimated to be 1 out of 125 births [3,4], and approximately
40,000 infants are born annually with CHD [5]. In addition,
the 2009 annual summary of vital statistics in the United
States showed that CHDs were the leading cause of all birth
defect-related infant deaths [6].
CHDs originate in the early weeks of pregnancy when
the heart is forming and are usually diagnosed either
prenatally or soon after birth, although some defects are not
diagnosed until later in childhood or even in adulthood.
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unless otherwise stated.with CHD are reduced birth weight [3,7-11] and increased
incidence of clinically low and very low birth weight infants,
i.e. <2,500 g and <1,500 g, respectively [3,10,12,13].
An additional highly consistent finding is that infants
with CHD are often born prematurely, suggesting that
the association of CHD with low birth weight may be
attributed, at least in part, to prematurity or reduced
gestational age [8,14-18]. Whether CHD, low birth
weight, and prematurity are all co-outcomes of a common,
underlying teratogenic influence such as maternal environ-
mental exposure is plausible but as yet unknown [19-21].
The aim of our study was to investigate the relationship
between the CHD status of infants and their birth weight
by considering gestational age as a mediating variable
(mediator), i.e., a variable that “mediates” the relation
between the predictor (an infant’s CHD status) and the
outcome (birth weight). Using statistical mediation
analysis, we considered gestational age as the mediator, we
assessed its indirect effect on the relationship of interest,
and we estimated the proportion of the effect of CHDThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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ator, taking into account infant and maternal covariates
known to affect birth weight and CHD status.
Methods
Study population
The Baltimore-Washington Infant Study was a population-
based case–control study of the potential risk factors of
CHD, conducted from 1981 to 1989 in Maryland, the
District of Columbia, and Northern Virginia. The
study enrolled all live-born infants with CHD and a
randomly selected sample of controls that was representa-
tive of all regional live births. Controls were randomly
sampled at birth hospitals in the region during the
same time period. Parents of cases and controls were
interviewed at home by trained personnel within one year
of the infant’s birth and asked questions concerning
medical and demographic/socioeconomic factors, as well
as questions regarding cigarette smoking and alcohol con-
sumption. Mothers reported the infant’s birth weight in
pounds and ounces, which we converted to grams for this
analysis. Gestational age was calculated from the mother’s
report of the infant’s date of birth in relation to her
reported expected delivery date [1,13]. The diagnosis of each
case was made during the first year of life and confirmed by
pediatric cardiologists using echocardiography, cardiac
catheterization, surgery, or autopsy. Detailed information
about the Baltimore-Washington Infant Study dataset as
well as the study in general has been reported previously
[1,22,23]. The study was approved by the Institutional
Review Board of the University of Maryland, Baltimore.
From the extensive Baltimore-Washington Infant
Study dataset, we selected variables that are known from
prior reports to influence both infants’ CHD status and
birth weight, as potential confounders for our study.
These included an infant’s sex [24-26] and race [27-29], as
well as maternal age [27,30,31], education [31], pre-existing
maternal diabetes [32,33], parity [30,34,35], and cigarette
smoking during the first trimester [19,31,32,35]. We
excluded twins and other multiple births due to their much
smaller birth weights relative to singletons and their high
prevalence of premature births.
Statistical analysis
In mediation analysis, the main interest is to assess how
much the effect of an exposure on a response variable is
mediated through an intermediate variable, oftentimes
called the mediator [36]. Thus, the intermediate variable lies
on the causal pathway between the exposure (independent
variable) and the response (dependent variable). Based on
the statistical mediation approach proposed by Baron
and Kenny [37], the mediation analysis is carried out by
partitioning the total effect of the independent variable on
the dependent variable into its mediated (or indirect) effectand its direct effect [38]. The mediated effect is the effect
of the independent variable on the dependent variable
accounted for by the mediator, whereas the direct effect is
the effect of the independent variable on the dependent
variable holding the mediator constant. Imai et al. [39] and
MacKinnon [40] operationalized the procedure using
a regression-based approach by proposing the implementa-
tion of three separate, but related, regression models. In the
first model (Model 1), the dependent variable is regressed
on the independent variable; in the second model (Model
2), the mediator is regressed on the independent variable;
and in the third model (Model 3), the dependent variable is
regressed on both the mediator and the independent
variable. An attractive feature of this regression-based
approach is that additional potential confounders and
other terms (e.g., interactions between covariates) can
be included.
After obtaining parameter estimates from these three
regression models, we estimated the mediated effect as the
product of the estimate of the effect of the independent
variable on the mediator from Model 2 with the estimate
of the effect of the mediator on the dependent variable
from Model 3 [37,40-43]. The 95% confidence intervals for
the mediation effect were calculated and compared using
three different approaches: (1) the Wald statistic approach,
based on the Sobel test [44]; (2) the likelihood ratio test
approach [40], which is based directly on the likelihood
function rather than on the quadratic approximation of
the log-likelihood function used by the Wald statistic
approach; and (3) the bootstrap approach [43,45-47].
From an epidemiological point of view, in order to
explore the mechanism of exposure-disease relations,
it is important to assess the mediated (indirect) effect.
A relevant way of expressing mediated effects is by
considering the “proportion mediated”, which is the
proportion of the total effect explained by a particular
mediator [38-40,48]. The mediation proportion was
estimated by taking the ratio of the estimate of the
mediated effect to the estimate of the total effect (i.e.,
the effect from Model 1). We used and compared
three different approaches [40] to calculate the 95%
confidence intervals for the mediation proportion: (1)
the Delta method [49] to compute the standard error
of the mediation proportion so as to construct the
confidence intervals for the mediation proportion; (2)
the Fieller’s method [50]; and (3) the bootstrap approach
[45,51-53]. The results from the bootstrap approach were
compared, for the purpose of justification, with the results
from the other two approaches. During the bootstrap
approach, we used 500 draws (i.e., bootstrap resamples)
for point estimation as well as construction of confidence
intervals. The mediation analyses were performed using
SAS 9.3 (SAS Institute Inc., Cary, NC) and R (R Foundation
for Statistical Computing, Vienna, Austria).
Table 1 Characteristics of infants in the BWIS dataset
Group p-value
Cases1
(n = 3362)
Controls
(n = 3564)
Dependent and mediating variables
Birth–weight, grams: mean (SD) 3071 (729) 3353 (603) <0.0001
Gestational age, weeks: mean (SD) 38.9 (2.7) 39.6 (2.2) <0.0001
Covariates
Infant’s sex (%)
male 1661 (49.41) 1812 (50.84) 0.2320
female 1701 (50.59) 1752 (49.16)
Infant’s race (%)
white 2175 (64.69) 2358 (66.16)
African American 1057 (31.44) 1108 (31.09) 0.0274
other 130 (3.87) 98 (2.75)
Mother’s age at conception
(SD) years
26.72 (5.92) 26.27 (5.72) 0.0014
Previous pregnancies (%)
never pregnant 1014 (30.16) 1154 (32.38) 0.0006
one 986 (29.33) 1154 (30.72)
two 661 (19.66) 709 (19.89)
≥ three 701 (20.85) 606 (17.00)
Maternal smoking status (%)
Non smoker 2150 (63.95) 2298 (64.48) 0.3363
1–10 cigarettes/day 535 (15.91) 565 (15.85)
11–20 cigarettes/day 480 (14.28) 526 (14.76)
21–39 cigarettes/day 143 (4.25) 136 (3.82)
40 or more cigarettes/day 54 (1.61) 39 (1.09)
Mother’s education (%)
6 years, or less, completion 26 (0.78) 22 (0.62)
7–9 years completion 220 (6.57) 228 (6.42)
10–11 years completion 358 (10.7) 405 (11.4) 0.2248
12 years completion 1265 (37.8) 1259 (35.42)
13 years, or more, completion 1478 (44.16) 1640 (46.15)
Pre-pregnancy diabetes (%)
No 3283 (98.09) 3531 (99.35) <0.0001
Yes 64 (1.91) 23 (0.65)
Method of Delivery
Vaginal 2307 (68.34) 2694 (75.42) <0.0001
Caesarian section 1069 (31.66) 878 (24.58)
1Cases included 123 with laterality and looping defects, 578 with conotruncal
(outflow tract) defects, 288 with endocardial cushion (atrioventricular septal)
defects), 275 with pulmonic valve stenosis, 519 with left-sided obstructive
defects, 859 with ventricular septal defect, 290 with atrial septal (secundum) defect,
82 with patent arterial duct, and 347 with other cardiovascular malformations.
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The parents of all participants signed an informed
consent agreement to participate in the original Baltimore-
Washington Infant Study protocol, which was approved by
the Instututional Review Board of the University of
Maryland, Baltimore. The present analysis was performed
on data abstracted without identifiers.
Results
The Baltimore-Washington Infant Study enrolled a total
of 3,377 cases and 3,572 controls from 1981 to 1989.
Fifteen cases and 8 controls were dropped from the
analyses due to missing values. Characteristics of the study
population are shown in Table 1. The average birth
weights of the cases and controls were 3071 (Standard
deviation = 729) and 3353 (Standard deviation = 603) grams,
respectively (p < 0.0001), confirming the expected deficit
among the infants with CHD. The average gestational ages
were found to be 38.9 (standard deviation = 2.7) and 39.6
(standard deviation = 2.2) weeks, respectively, and the
difference was statistically significant (p < 0.0001). Infant
sex, maternal education, and maternal cigarette smoking
were distributed similarly in cases and controls (p > 0.05),
whereas the case–control differences in infant race,
maternal age, previous pregnancies, pre-pregnancy
diabetes, and method of delivery were each statistically
significant. Based on these results we explored these
variables as potential covariates in the subsequent
statistical models.
The parameter estimates, standard errors, and p-values
from the three regression models (Model 1, Model 2,
and Model 3) are shown in Table 2. During the model
building steps, interaction terms between the variables
were considered, but none of them were found to be
statistically significant (p > 0.10; where p = 0.10 was
used as statistical cut-point for the inclusion of interaction
terms into the final models). Race of the infant, maternal
age, education and parity were not statistically significant
in any of the models considered and were not included in
the final models. Two covariates – sex of the infant and
maternal smoking status – were associated with infant
birth weight, with or without gestational age in the model.
In Model 1, the CHD status had a statistically significant
detrimental effect on birth weight (p < 0.0001, Table 2(a)).
Adjusted for sex of infants and maternal smoking status,
on average, infants with CHD had a birth weight 279 g
lower (95% confidence interval, 248–310) than that of
infants without CHD. The CHD status also had a
small but statistically significant association with gestational
age in Model 2 (p < 0.0001, Table 2(b)). When CHD
status and gestational age of infants were both con-
sidered as predictors of the birth weight of the infants
(Model 3), both variables were found to be statisti-
cally significant (p < 0.0001 each, Table 2(c)). Adjustedfor gender, maternal smoking, and gestational age, the
difference between the birth weight of infants with
CHD and infants without CHD decreased to 165.9 g
(95% confidence interval, 141–190).
Table 2 Results from the three regression models: having birth weight as the dependent variable (Model 1 and
Model 3) and having gestational age as the dependent variable (Model 2)
Variable Parameter estimate Standard error t–value p–value
(a) Model 1 (dependent variable is birth weight in grams)
Intercept 3349.39 14.82 226.07 <0.0001
CHD1 −279.00 15.82 −17.64 <0.0001
Child’s sex2 137.53 15.81 8.70 <0.0001
1–10 cigarettes/day3 −191.44 22.14 −8.64 <0.0001
11–20 cigarettes/day3 −167.19 22.96 −7.28 <0.0001
21–39 cigarettes/day3 −224.75 40.60 −5.54 <0.0001
40 or more cigarettes/day3 −240.76 68.92 −3.49 0.0005
(b) Model 2 (dependent variable is gestational age in weeks)
Intercept 39.64 0.06 708.67 <0.0001
CHD1 −0.69 0.06 −11.54 <0.0001
Child’s sex2 0.04 0.06 0.64 0.5198
1–10 cigarettes/day3 −0.26 0.08 −3.16 0.0016
11–20 cigarettes/day3 −0.21 0.09 −2.46 0.0138
21–39 cigarettes/day3 −0.21 0.15 −1.38 0.1662
40 or more cigarettes/day3 −0.07 0.26 −0.27 0.7880
(c) Model 3 (dependent variable is birth weight in grams)
Intercept −3157.30 99.75 −31.65 <0.0001
Gestational age 164.13 2.50 65.68 <0.0001
CHD1 −165.92 12.53 −13.24 <0.0001
Child’s sex2 131.23 12.41 10.57 <0.0001
1–10 cigarettes/day3 −148.04 17.39 −8.51 <0.0001
11–20 cigarettes/day3 −132.14 18.03 −7.33 <0.0001
21–39 cigarettes/day3 −189.91 31.87 −5.96 <0.0001
40 or more cigarettes/day3 −229.28 54.09 −4.24 <0.0001
1Reference is infants without CHD.
2Reference is female infants group.
3Reference is nonsmoker mothers group.
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From these three regression models, we observed that
the total effect of CHD status on infant birth weight was
279 g (Table 2(a)). The direct effect of the CHD status
on birth weight was 166 g (Table 2(c)), and the mediated
effect was 164.13 × 0.69 = 113 g (95% confidence interval,
93.6–132.6 based on the Wald statistic approach, and
99.9–117.8 based on the likelihood-based approach;
Table 3(a)). The point estimate of the mediated effect
found from the bootstrap approach was 113.5 g, which
is closely comparable to the estimates found from Wald
statistic and likelihood-based approaches (95% confidence
interval, 92.4–134.2, Table 3(a)). The 95% confidence
interval from the likelihood-based approach was narrower
compared to the Wald statistic and bootstrap approaches.
The estimated mediation proportion was 40.5%
using the Wald statistic (Delta) and Fieller’s methods
(95% confidence intervals, 32.2%–48.8% and 35.2%–45.9%,respectively), and 40.7% (95% confidence interval,
34.7%–46.6%) using the bootstrap method (Table 3
(b)). In other words, adjusted for gender and maternal
smoking, approximately 41% of the effect of the CHD
status on birth weight was mediated by the gestational age
of the infant, and the remaining 59% was a direct effect of
CHD status on birth weight.
We also investigated the mediation proportion for the
two sexes separately. The mediation proportion was
45.2% (95% Fieller’s confidence interval, 36.6%–54.0%)
for males and 36.7% (95% Fieller’s confidence interval,
29.8%–43.5%) for females; the difference in these two
proportions was not statistically significant (p = 0.3342).
Discussion
In studying the association between an independent and
dependent variable, there are situations in which the
independent variable affects the outcome variable both
Table 3 Point estimates and 95% confidence intervals (CI) of the mediated effect and mediation proportion using
three approaches
(a). MEDIATED EFFECT
Estimation method Wald statistic method Likelihood-based method Bootstrap method
Estimate (95% CI) 113.08 (93.6–132.6) 113.08 (99.9–117.8) 113.51 (92.4–134.2)
(b). MEDIATION PROPORTION
Estimation method The delta method Fieller’s method Bootstrap method
Estimate (95% CI) 40.5% (32.2%–48.8%) 40.5% (35.2%–45.9%) 40.7% (34.7%–46.6%)
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(the mediator) which in turn influences the dependent
variable. Thus, the relationships between variables are
often complex and cannot be well modeled by a single
regression equation, while consideration of a mediator
allows researchers to more fully explore the separate and
combined effects of interest. The problem of CHD as a
potential cause of reduced birth weight in affected infants
is amenable to this approach because birth weight itself is
highly dependent on gestational age, which in turn may be
influenced by CHD to some extent. Consistent with this
view, several studies have previously documented the
association of CHD in newborns with their decreased
birth weight and gestational age, relative to unaffected
infants, but to our knowledge, the mediation effect
has not been directly assessed in prior published research
[1,13]. Additionally, we were able to account for the effects
of additional covariates of birth weight in our models:
males had consistently higher birth weights than females
on average in this study, while maternal smoking resulted
in decreased birth weight in a dose-dependent manner.
Both effects were independent of gestational age. Caesarian
section, a possible indicator for a planned inducement of
early delivery for a fetus known or suspected to have
birth defects, was more common among cases than
controls. While it reduced the mean gestational age
of cases by 0.5 weeks (p = 0.002) and had a lesser
affect on controls (−0.3 weeks, p = 0.99), the use of
caesarian section did not significantly affect the mean
birth weights of infants in this study.
This study has several strengths and limitations. The
data is from the Baltimore-Washington Infant Study,
which had achieved complete ascertainment of cases in
the region and a population-based random sample of
controls; therefore selection bias is extremely unlikely as
an explanation for our findings. On the other hand, we
cannot rule out the possibility of recall bias of infant
birth weight, nor random (non-systematic) errors in
recalling the weight or the estimated date of delivery.
There are also statistical issues that should be considered
in evaluating our results. We confined our analysis to the
linear effects of variables on birth weight, but future work
should consider possible non-linear effects as well. While
our use of regression models permitted us to assess thesemediation effects, the technique can become unwieldy for
more complex situations [40,44,54]. For example, the
original Baltimore-Washington Infant Study dataset
contains a large number of variables that could be explored
jointly as mediators and/or covariates. Furthermore, it
would be interesting to consider a common teratogen
model, in which a factor such as maternal smoking was
modeled as affecting both the occurrence of the malforma-
tion and contributing simultaneously to premature birth
and decreased weight at birth.
Conclusions
In summary, we used data from a population-based
epidemiological study to evaluate the mediation effect
of gestational age in explaining the relationship between
CHD and decreased birth weight of infants. The results
suggest that this mediation accounts for a substantial
proportion (about 41%) of the latter association, which was
not apparent in previous research in this field due to the
limitations of conventional statistical association methods.
Further research is needed to confirm these findings in
other populations and to explore even more complex
methods such as structural equation modeling [55,56].
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